Update on Checkpoint Inhibitors in Lung Cancer
By Erik J. MacLaren, PhD
The growing number of checkpoint inhibitors currently being developed, without question, has ushered in a new era in clinical oncology,...
Immunotherapy
Feature articles about current research in immunology that has significant impact or impact potential on thoracic oncology.
